3M launches software to promote medical necessity compliance

3M Health Information Systems, has integrated its Medical Necessity Online and Ambulatory Revenue Management Software, to provide access to all pre-service medical necessity data.

Published By MarketLine

3M launches two new respirators

3M has introduced two new Niosh N95 respirators for use by the general public in public health medical emergencies.

Published By MarketLine

3M licenses Cambridge Consultants's dry powder inhaler technology

3M, a diversified technology company, has announced that its drug delivery systems division has signed an exclusive technology licensing and purchase agreement with Cambridge Consultants for its Conix dry powder inhaler technology platform.

Published By MarketLine

3M Pharmaceuticals granted FDA approval for Aldara

3M has confirmed that the FDA has approved its Aldara product, the first prescription therapy in nearly a decade for the treatment of superficial basal cell carcinoma, a type of nonmelanoma skin cancer.

Published By MarketLine

3M Reports First Quarter Results And Announces Company Restructuring

Published By MarketLine

3M reports Phase II genital herpes trial results and Phase III initiation

Published By MarketLine

3M Reports Third-Quarter, Nine-Month Results

3M has reported sales and earnings for the third quarter and first nine months of 2001. Third-quarter net income - excluding non-recurring items - totaled $437 million, or $1.10 per share, down 12 percent from $499 million, or $1.25 per share, in the same quarter of 2000. Currency effects reduced earnings for the quarter by 6 cents per share, or 5 percent.

Published By MarketLine

3M sells pharmaceuticals business for $2.1 billion

Diversified technology company 3M is selling its pharmaceutical business around the world for $2.1 billion.

Published By MarketLine

3M sells pharmaceuticals business in Europe

Diversified conglomerate 3M has completed the sale of its European pharmaceutical business to Meda AB. Terms of the transaction were not disclosed.

Published By MarketLine

3M signs licensing agreement with Avant

3M Drug Delivery Systems has signed a non-exclusive license agreement with Celldex Therapeutics, a wholly-owned subsidiary of Avant Immunotherapeutics.

Published By MarketLine